Merav Bassan - Biomx Chief Officer
| PHGE Stock | USD 0.54 0.05 10.20% |
Insider
Merav Bassan is Chief Officer of Biomx Inc
| Age | 58 |
| Address | 22 Einstein Street, Ness Ziona, Israel, 7414003 |
| Phone | 972 7 2394 2377 |
| Web | https://www.biomx.com |
Biomx Management Efficiency
The company has return on total asset (ROA) of (0.3265) % which means that it has lost $0.3265 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2129) %, meaning that it created substantial loss on money invested by shareholders. Biomx's management efficiency ratios could be used to measure how well Biomx manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.47. In addition to that, Return On Capital Employed is expected to decline to -0.62. At present, Biomx's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 1.7 M, whereas Non Currrent Assets Other are projected to grow to (24.7 M).Similar Executives
| Showing other executives | INSIDER Age | ||
| MBA MD | Immix Biopharma | 49 | |
| DSc MSE | Immix Biopharma | 75 | |
| Jay Cross | Sonnet Biotherapeutics Holdings | 53 | |
| LaBella MS | ZyVersa Therapeutics | 66 | |
| Susan Dexter | Sonnet Biotherapeutics Holdings | 69 | |
| CPA CTP | Cns Pharmaceuticals | 44 | |
| Manuel Dafonseca | Sonnet Biotherapeutics Holdings | N/A | |
| Nandan BS | Immix Biopharma | 62 | |
| MD FACP | Sonnet Biotherapeutics Holdings | 66 | |
| Pablo MD | ZyVersa Therapeutics | N/A | |
| Donald Picker | Cns Pharmaceuticals | 78 | |
| JD MBA | Immix Biopharma | N/A | |
| Karen Cashmere | ZyVersa Therapeutics | 72 | |
| Waldemar Priebe | Cns Pharmaceuticals | N/A | |
| Gabriel BA | Immix Biopharma | 37 | |
| John Cini | Sonnet Biotherapeutics Holdings | 71 | |
Management Performance
| Return On Equity | -1.21 | ||||
| Return On Asset | -0.33 |
Biomx Inc Leadership Team
Elected by the shareholders, the Biomx's board of directors comprises two types of representatives: Biomx inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biomx. The board's role is to monitor Biomx's management team and ensure that shareholders' interests are well served. Biomx's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biomx's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan MBA, CEO Director | ||
| Assaf Oron, Chief Officer | ||
| Eran MD, Scientific Founder | ||
| Marina CPA, CFO Secretary | ||
| Merav Bassan, Chief Officer | ||
| Avraham Gabay, Interim Officer | ||
| Pr Sorek, Scientific Founder | ||
| Inbar GahaliSass, VP RD | ||
| Inbal BenjaminiElran, CHRO |
Biomx Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biomx a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.21 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 13.79 M | ||||
| Shares Outstanding | 18.18 M | ||||
| Shares Owned By Insiders | 11.67 % | ||||
| Shares Owned By Institutions | 52.30 % | ||||
| Number Of Shares Shorted | 23.03 K | ||||
| Price To Book | 0.46 X | ||||
| Revenue | (357 K) | ||||
| EBITDA | (22.82 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Biomx Inc is a strong investment it is important to analyze Biomx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biomx's future performance. For an informed investment choice regarding Biomx Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.26) | Return On Assets (0.33) | Return On Equity (1.21) |
The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.